Pulmonary Fibrosis News Columnist and Forum Moderator Charlene Marshall reads an article summarizing the intentions of a new institute, which aims to leave no rare disease patient behind. 

The Institute for Life Changing Medicines is paving the way for pharmaceutical companies and others to make drug development and distribution more accessible for rare disease patients – many of whom have the largest therapeutic need, but are often left behind when it comes to therapies for their rare disease. 

Are you interested in learning more about Pulmonary Fibrosis? If so, please visit: https://pulmonaryfibrosisnews.com

New Institute Aims to Leave No Rare Disease Patient Behind

Pulmonary Fibrosis News is committed to creating a 24-hour news cycle of the latest science and research news related to addressing PF. While there is a great deal of research going on right now for treating and eventually curing PF, that news is rarely reported. Our team of writers and editors are proven professionals in the science and research fields who are committed to sourcing and presenting new research news in a format that patients can easily understand.